製品名:5,7-dichloro-8-fluoro-2-(methylsulfanyl)-3H,4H-pyrido[4,3-d]pyrimidin-4-one

IUPAC Name:5,7-dichloro-8-fluoro-2-(methylsulfanyl)-3H,4H-pyrido[4,3-d]pyrimidin-4-one

CAS番号:2763157-90-8
分子式:C8H4Cl2FN3OS
純度:95%+
カタログ番号:CM1043992
分子量:280.1

包装単位 有効在庫 価格(USD) 数量
CM1043992-100mg in stock Ȭțȁ
CM1043992-250mg in stock Ȭǧƻ
CM1043992-1g in stock ȁŴƀ
CM1043992-5g in stock Ȭțƀƀ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:2763157-90-8
分子式:C8H4Cl2FN3OS
融点:-
SMILESコード:CSC1=NC2=C(C(=O)N1)C(=NC(=C2F)Cl)Cl
密度:
カタログ番号:CM1043992
分子量:280.1
沸点:
MDL番号:
保管方法:

Category Infos

Column Infos

HRS-4642
HRS-4642 is a high affinity, selective, long-acting, and non-covalent KRAS G12D inhibitor, with an affinity constant of 0.083 nM. HRS-4642 demonstrated robust efficacy against KRAS G12D-mutant cancers both in vitro and in vivo. Importantly, in a phase 1 clinical trial, HRS-4642 exhibited promising anti-tumor activity in the escalating dosing cohorts. Furthermore, the sensitization and resistance spectrum for HRS-4642 was deciphered through genome-wide CRISPR-Cas9 screening, which unveiled proteasome as a sensitization target. HRS-4642, either as a single agent or in combination with carfilzomib, reshaped the tumor microenvironment toward an immune-permissive one.

Related Products